Detalles de la búsqueda
1.
Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis.
Int J Clin Oncol
; 28(12): 1651-1658, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37658926
2.
Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non-clear cell renal cell carcinoma: Real-world data from a Japanese multicenter retrospective study.
Int J Urol
; 30(9): 714-721, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36541136
3.
Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart review.
Int J Urol
; 30(9): 762-771, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37248753
4.
Potential therapeutic effects of adjuvant chemotherapy after neoadjuvant chemotherapy for locally advanced muscle-invasive bladder cancer.
Jpn J Clin Oncol
; 52(4): 388-396, 2022 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35106598
5.
Significance of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer.
Jpn J Clin Oncol
; 51(2): 287-295, 2021 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32893303
6.
On-treatment C-reactive protein control could predict response to subsequent anti-PD-1 treatment in metastatic renal cell carcinoma.
Int J Clin Oncol
; 26(8): 1500-1505, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34101038
7.
A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data.
Int J Clin Oncol
; 25(8): 1533-1542, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32519026
8.
Thiamine deficiency in a patient with recurrent renal cell carcinoma who developed weight loss with normal appetite and loss of energy soon after nivolumab treatment.
Palliat Support Care
; 18(2): 241-243, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31535612
9.
Clinical outcome of high dose rate brachytherapy with external beam radiotherapy for high-risk prostate cancer: a single institutional retrospective study.
Jpn J Clin Oncol
; 49(1): 87-91, 2019 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30476164
10.
Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy.
Jpn J Clin Oncol
; 49(8): 780-785, 2019 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31063191
11.
Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinoma.
Jpn J Clin Oncol
; 49(1): 69-76, 2019 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30407543
12.
Patient age was an independent predictor of cancer-specific survival in male patients with upper tract urothelial carcinoma treated by radical nephroureterectomy.
Jpn J Clin Oncol
; 46(6): 554-559, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26962241
13.
Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experience.
J Urol
; 193(4): 1122-8, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25444957
14.
Prognostic Impact of Renin-Angiotensin System Blockade on Renal Cell Carcinoma After Surgery.
Ann Surg Oncol
; 22(11): 3751-9, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25691280
15.
Metastatic behavior of upper tract urothelial carcinoma after radical nephroureterectomy: association with primary tumor location.
Ann Surg Oncol
; 21(3): 1038-45, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24217788
16.
Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma.
Ann Surg Oncol
; 21(9): 3151-8, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24682698
17.
A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy.
Ann Surg Oncol
; 21(12): 4041-8, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24912614
18.
New risk stratification for adjuvant nivolumab for high-risk muscle-invasive urothelial carcinoma.
BJUI Compass
; 5(2): 281-288, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38371203
19.
Regulation of monocyte chemoattractant protein-1 through angiotensin II type 1 receptor in prostate cancer.
Am J Pathol
; 180(3): 1008-1016, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22226738
20.
Patient characteristics and outcomes in metastatic upper tract urothelial carcinoma after radical nephroureterectomy: the experience of Japanese multi-institutions.
BJU Int
; 112(2): E28-34, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23795795